Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 Apr 15;18(8):4207.
doi: 10.3390/ijerph18084207.

Effects of a Rehabilitation Programme Using a Nasal Inspiratory Restriction Device in COPD

Affiliations
Randomized Controlled Trial

Effects of a Rehabilitation Programme Using a Nasal Inspiratory Restriction Device in COPD

Jose L Gonzalez-Montesinos et al. Int J Environ Res Public Health. .

Abstract

Chronic obstructive pulmonary disease (COPD) patients are characterised for presenting dyspnea, which reduces their physical capacity and tolerance to physical exercise. The aim of this study was to analyse the effects of adding a Feel-Breathe (FB) device for inspiratory muscle training (IMT) to an 8-week pulmonary rehabilitation programme. Twenty patients were randomised into three groups: breathing with FB (FBG), oronasal breathing without FB (ONBG) and control group (CG). FBG and ONBG carried out the same training programme with resistance, strength and respiratory exercises for 8 weeks. CG did not perform any pulmonary rehabilitation programme. Regarding intra group differences in the value obtained in the post-training test at the time when the maximum value in the pre-training test was obtained (PostPRE), FBG obtained lower values in oxygen consumption (VO2, mean = -435.6 mL/min, Bayes Factor (BF10) > 100), minute ventilation (VE, -8.5 L/min, BF10 = 25), respiratory rate (RR, -3.3 breaths/min, BF10 = 2), heart rate (HR, -13.7 beats/min, BF10 > 100) and carbon dioxide production (VCO2, -183.0 L/min, BF10 = 50), and a greater value in expiratory time (Tex, 0.22 s, BF10 = 12.5). At the maximum value recorded in the post-training test (PostFINAL), FBG showed higher values in the total time of the test (Tt, 4.3 min, BF10 = 50) and respiratory exchange rate (RER, 0.05, BF10 = 1.3). Regarding inter group differences at PrePOST, FBG obtained a greater negative increment than ONBG in the ventilatory equivalent of CO2 (EqCO2, -3.8 L/min, BF10 = 1.1) and compared to CG in VE (-8.3 L/min, BF10 = 3.6), VCO2 (-215.9 L/min, BF10 = 3.0), EqCO2 (-3.7 L/min, BF10 = 1.1) and HR (-12.9 beats/min, BF10 = 3.4). FBG also showed a greater PrePOST positive increment in Tex (0.21 s, BF10 = 1.4) with respect to CG. At PreFINAL, FBG presented a greater positive increment compared to CG in Tt (4.4 min, BF10 = 3.2) and negative in VE/VCO2 intercept (-4.7, BF10 = 1.1). The use of FB added to a pulmonary rehabilitation programme in COPD patients could improve tolerance in the incremental exercise test and energy efficiency. However, there is only a statically significant difference between FBG and ONBG in EqCO2. Therefore, more studies are necessary to reach a definitive conclusion about including FB in a pulmonary rehabilitation programme.

Keywords: cardiopulmonary exercise test; chronic pulmonary obstructive pulmonary disease; inspiratory muscle training; physical exercise.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flowchart of the study.
Figure 2
Figure 2
Types (left) and positioning (right) of the FeelBreathe device.
Figure 3
Figure 3
Graphical representation of temporal points selected for statistical analyses.
Figure 4
Figure 4
Significant intra-group differences for FBG in VO2 (A), VE (B), BF (C), VCO2 (D), HR (E), Tex (F), RER (G) and Tt (H). %Change indicates percentage of change; Δ, increment; BF10, Bayes Factor; HDI, highest density interval. Significant differences are highlighted in bold.
Figure 5
Figure 5
Significant intra-group difference for ONBG in HR. %Change indicates percentage of change; Δ, increment; BF10, Bayes Factor; HDI, highest density interval. Significant differences are highlighted in bold.
Figure 6
Figure 6
Significant intra-group difference for CG in VE/VCO2 intercept. %Change indicates percentage of change; Δ, increment; BF10, Bayes Factor; HDI, highest density interval. Significant differences are highlighted in bold.
Figure 7
Figure 7
Significant inter-group differences between FBG and ONBG in EqCO2 at PostPRE (A); between FBG and CG in VE (B), VCO2 (C), EqCO2 (D), HR (E) and Tex (F) at PostPRE; and between FBG and CG in Tt (G) and VE/VCO2 intercept (H). %Change indicates percentage of change; Δ, increment; BF10, Bayes Factor; HDI, highest density interval. Significant differences are highlighted in bold.

References

    1. Rabe K.F., Watz H. Chronic Obstructive Pulmonary Disease. Lancet. 2017;389:1931–1940. doi: 10.1016/S0140-6736(17)31222-9. - DOI - PubMed
    1. Vogelmeier C.F., Criner G.J., Martinez F.J., Anzueto A., Barnes P.J., Bourbeau J., Celli B.R., Chen R., Decramer M., Fabbri L.M., et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. Am. J. Respir. Crit. Care Med. 2017;195:557–582. doi: 10.1164/rccm.201701-0218PP. - DOI - PubMed
    1. McCarthy B., Casey D., Devane D., Murphy K., Murphy E., Lacasse Y. Pulmonary Rehabilitation for Chronic Obstructive Pulmonary Disease. Cochrane Database Syst. Rev. 2015:CD003793. doi: 10.1002/14651858.CD003793.pub3. - DOI - PMC - PubMed
    1. Garvey C., Bayles M.P., Hamm L.F., Hill K., Holland A., Limberg T.M., Spruit M.A. Pulmonary Rehabilitation Exercise Prescription in Chronic Obstructive Pulmonary Disease: Review of Selected Guidelines: An Official Statement from the American Association of Cardiovascular and Pulmonary Rehabilitation. J. Cardiopulm. Rehabil. Prev. 2016;36:75–83. doi: 10.1097/HCR.0000000000000171. - DOI - PubMed
    1. Gosselink R., De Vos J., van den Heuvel S.P., Segers J., Decramer M., Kwakkel G. Impact of Inspiratory Muscle Training in Patients with COPD: What Is the Evidence? Eur. Respir. J. 2011;37:416–425. doi: 10.1183/09031936.00031810. - DOI - PubMed

Publication types